(Q39023327)

8 September 2017

Detection of atovaquone and Malarone resistance conferring mutations in Plasmodium falciparum cytochrome b gene (cytb). (English)

1 reference

8 September 2017

Plasmodium falciparum

0 references

Gil JP

1

0 references

Ana Paula Arez

1 reference

ORCID Public Data File 2021

author name string

Nogueira F

2

1 reference

8 September 2017

Strömberg-Nörklit J

3

1 reference

8 September 2017

Lindberg J

4

1 reference

8 September 2017

Carrolo M

5

1 reference

8 September 2017

Casimiro C

6

1 reference

8 September 2017

Lopes D

7

1 reference

8 September 2017

Arez AP

8

1 reference

8 September 2017

Cravo PV

9

1 reference

8 September 2017

Rosário VE

10

1 reference

8 September 2017

1 April 2003

1 reference

Molecular and Cellular Probes

8 September 2017

1 reference

8 September 2017

17

1 reference

8 September 2017

2-3

1 reference

8 September 2017

85-89

1 reference

Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity

8 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Evaluation of atovaquone in the treatment of patients with uncomplicated Plasmodium falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

A mechanism for the synergistic antimalarial action of atovaquone and proguanil

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Atovaquone resistance in malaria parasites

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

A clonal Plasmodium falciparum population in an isolated outbreak of malaria in the Republic of Cabo Verde.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Human malaria parasites in continuous culture

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Reduced extension temperatures required for PCR amplification of extremely A+T-rich DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy

1 reference

https://api.crossref.org/works/10.1016%2FS0890-8508%2803%2900006-9

7 January 2021

10.1016/S0890-8508(03)00006-9

Identifiers

DOI

1 reference

8 September 2017

1 reference